Dr. Shi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S 11th St
# Bodine
Philadelphia, PA 19107Phone+1 215-955-6702Fax+1 215-955-5331
Education & Training
- University of FloridaResidency, Radiation Oncology, 2006 - 2010
- University of Florida College of MedicineInternship, Transitional Year, 2005 - 2006
- Shanghai Medical UniversityClass of 1997
Certifications & Licensure
- DE State Medical License Current
- NJ State Medical License 2017 - 2025
- PA State Medical License 2010 - 2024
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Clinical Trials
- Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases Start of enrollment: 2005 Oct 01
- Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases Start of enrollment: 2009 Mar 01
- A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies Start of enrollment: 2008 Apr 10
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsPlan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife.Haisong Liu, David W. Andrews, James J. Evans, Maria Werner-Wasik, Yan Yu
Frontiers in Oncology. 2016-02-11 - 63 citationsMulti-Institutional Dosimetric Evaluation of Modern Day Stereotactic Radiosurgery (SRS) Treatment Options for Multiple Brain Metastases.Irina Vergalasova, Haisong Liu, Michelle Alonso-Basanta, Lei Dong, Jun Li
Frontiers in Oncology. 2019-06-07 - 42 citationsMulti-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metasta...Kerstin A. Eitz, Simon S. Lo, Hany Soliman, Arjun Sahgal, Aimee Theriault
JAMA Oncology. 2020-12-01
Journal Articles
- Multi-Institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients with Brain MetastasesSimon S Lo, Wenyin Shi, Kristin J Redmond, Mitchell Machtay, JAMA Oncology
Authored Content
- A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is VirtualJune 2021
Press Mentions
- Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 TrialMarch 24th, 2022
- Why Is Glioblastoma Such a Tough Nut to Crack?December 24th, 2019
- Over 1,000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific SoftwareNovember 16th, 2017
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: